NCT04685135 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 301
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 453
- units
- Participants
- groups
- description
- Participants with Non Small Cell Lung Cancer (NSCLC) with KRAS G12C mutation and who have received prior therapy with a platinum-based regimen and an immune checkpoint inhibitor were administered in 3-week cycle with Adagrasib tablet or capsule orally at a starting dose of 600 mg twice a day (BID).
- id
- BG000
- title
- Adagrasib
- description
- Participants with Non Small Cell Lung Cancer (NSCLC) with KRAS G12C mutation and who have received prior therapy with a platinum-based regimen and an immune checkpoint inhibitor were administered in 3-week cycle with intravenous infusion of Docetaxel at 75 mg/m\^2 over 1 hour or according to institutional practices.
- id
- BG001
- title
- Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.66
- value
- 63.6
- group Id
- BG001
- spread
- 7.81
- value
- 63.9
- group Id
- BG002
- spread
- 8.38
- value
- 63.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 150
- title
- Female
- measurements
- group Id
- BG000
- value
- 193
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 303
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 111
- group Id
- BG002
- value
- 310
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 94
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 129
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 135
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 216
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 72
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 109
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 111
- title
- Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 14
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 301
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 453
- units
- Participants
- groups
- description
- Participants with Non Small Cell Lung Cancer (NSCLC) with KRAS G12C mutation and who have received prior therapy with a platinum-based regimen and an immune checkpoint inhibitor were administered in 3-week cycle with Adagrasib tablet or capsule orally at a starting dose of 600 mg twice a day (BID).
- id
- BG000
- title
- Adagrasib
- description
- Participants with Non Small Cell Lung Cancer (NSCLC) with KRAS G12C mutation and who have received prior therapy with a platinum-based regimen and an immune checkpoint inhibitor were administered in 3-week cycle with intravenous infusion of Docetaxel at 75 mg/m\^2 over 1 hour or according to institutional practices.
- id
- BG001
- title
- Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.66
- value
- 63.6
- group Id
- BG001
- spread
- 7.81
- value
- 63.9
- group Id
- BG002
- spread
- 8.38
- value
- 63.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 150
- title
- Female
- measurements
- group Id
- BG000
- value
- 193
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 303
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 111
- group Id
- BG002
- value
- 310
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 94
- group Id
- BG001
- value
- 35
- group Id
- BG002
- value
- 129
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 135
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 216
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 72
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 109
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 111
- title
- Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 14
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle